66 children die in Africa, prompting the WHO to investigate Indian cough syrups

The World Health Organization (WHO) warned about four cough and cold syrups produced by an Indian manufacturer on Wednesday, claiming they may have contributed to the deaths of 66 children in The Gambia. The cough and cold medications produced by Maiden Pharmaceuticals in Haryana may have caused serious kidney problems, according to the WHO. The WHO advised against using them in its advisory.
The four cough and cold medications—Promethazine Oral Solution, Kofexmalin Baby Cough Syrup, Makoff Baby Cough Syrup, and Magrip N Cold Syrup—have been connected to the deaths of 66 children in The Gambia. The Indian manufacturer has not yet given guarantees about the safety and calibre of these products, according to a release from the WHO.

cough1665032082374 -

The WHO issued a medical product alert stating that “laboratory analysis of samples of each of the four items reveals that they contain excessive quantities of diethylene glycol and ethylene glycol as contaminants.” The WHO also cautioned that even though the items had only been discovered in The Gambia up until this point, they might have been exported to other nations.

Latest news

Broadridge Appoints Lauren Boyman to Global Marketing Leadership Role

Broadridge has named Lauren Boyman to a global marketing leadership role, marking a leadership development within the company’s marketing...

Orpat Appoints Unmesh Khambete as Chief Business Officer

Orpat has appointed Unmesh Khambete as its Chief Business Officer (CBO). In his new role, he will lead the...

Viral Pitch Appoints Adish Rai as Group President

Viral Pitch has appointed Adish Rai as its Group President to lead the organisation through its next phase of...

CarDekho Group Appoints Sudhir Pai as CEO – Auto Classifieds and Group Strategy Head

CarDekho Group has appointed Sudhir Pai as CEO – Auto Classifieds and Group Strategy Head. In this dual leadership...
spot_img

You might also likeRELATED
Recommended to you

spot_img